Loring Wolcott & Coolidge Fiduciary Advisors LLP Dexcom Inc Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.1 Billion
- Q2 2025
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Dexcom Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,988 shares of DXCM stock, worth $151,883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,988
Previous 1,988
-0.0%
Holding current value
$151,883
Previous $135,000
28.15%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DXCM
# of Institutions
1,094Shares Held
366MCall Options Held
5.74MPut Options Held
4.65M-
Vanguard Group Inc Valley Forge, PA47.5MShares$3.63 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.64 Billion0.09% of portfolio
-
Baillie Gifford & CO16.7MShares$1.28 Billion1.14% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.27 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$920 Million0.19% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $29.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...